Equities Analysts Issue Forecasts for BIOX Q2 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Investment analysts at Brookline Capital Management reduced their Q2 2025 earnings estimates for shares of Bioceres Crop Solutions in a note issued to investors on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of $0.14 for the quarter, down from their previous forecast of $0.28. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q3 2025 earnings at $0.02 EPS and FY2025 earnings at $0.16 EPS.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the prior year, the company posted ($0.07) EPS.

A number of other research firms also recently issued reports on BIOX. Oppenheimer reduced their price objective on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Lake Street Capital reduced their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Roth Mkm lowered their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Finally, Canaccord Genuity Group reduced their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a report on Wednesday. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $12.13.

Bioceres Crop Solutions Trading Down 3.9 %

Shares of Bioceres Crop Solutions stock opened at $6.17 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The firm has a market cap of $387.78 million, a price-to-earnings ratio of 308.65 and a beta of 0.49. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The business has a 50-day moving average price of $7.50 and a 200-day moving average price of $9.75.

Institutional Trading of Bioceres Crop Solutions

A number of institutional investors have recently bought and sold shares of the stock. Oak Family Advisors LLC raised its stake in shares of Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after acquiring an additional 1,208 shares during the period. Dimensional Fund Advisors LP raised its position in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after purchasing an additional 5,341 shares during the period. Stifel Financial Corp raised its position in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares during the period. Oppenheimer & Co. Inc. bought a new stake in Bioceres Crop Solutions in the first quarter worth about $139,000. Finally, Lazard Asset Management LLC purchased a new position in shares of Bioceres Crop Solutions during the first quarter valued at approximately $212,000. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.